Along with increased secretion of VEGF, MMP, and TGF-β, among others [12-17], these responses may lead to cell survival, invasion, and dissemination of sublethally irradiated cancer cells and thereby contribute to locoregional and distant treatment failure. The gene discussed is TGFB1; the disease is cancer.